Results 41 to 50 of about 150,695 (362)
Journal of the peripheral nervous system, 2020 Diabetic peripheral neuropathy (DPN) is one of the most widespread and disabling neurological conditions, accounting for half of all neuropathy cases worldwide. Despite its high prevalence, no approved disease modifying therapies exist.
A. Stino +3 more
semanticscholar +1 more source
Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy
Nutrients, 2020 Unhealthy dietary habits are major modifiable risk factors for the development of type 2 diabetes mellitus, a metabolic disease with increasing prevalence and serious consequences.
I. Preguiça +6 more
semanticscholar +1 more source
Point process models for sweat gland activation observed with noise [PDF]
Statistics in Medicine. 2021; 40:2055-2072, 2020 The aim of the paper is to construct spatial models for the activation of sweat glands for healthy subjects and subjects suffering from peripheral neuropathy by using videos of sweating recorded from the subjects. The sweat patterns are regarded as realizations of spatial point processes and two point process models for the sweat gland activation and ...
arxiv +1 more source
Diabetes: how to manage diabetic peripheral neuropathy
Drugs in Context, 2022 Diabetic peripheral neuropathy (DPN) is a major complication of diabetes mellitus. Tight glycaemic management focused on lowering haemoglobin A1C and increasing time in the target glucose range along with metabolic risk factor management form the cornerstone of DPN prevention.
Megha Gandhi +4 more
openaire +3 more sources
A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction [PDF]
Pain Research and Management, Volume 2017, Article ID 3517207, 2018 Background. Models of cancer-induced neuropathy are designed by injecting cancer cells near the peripheral nerves. The interference of tissue-resident immune cells does not allow a direct contact with nerve fibres which affects the tumor microenvironment and the invasion process. Methods.
arxiv +1 more source
Journal of Diabetes Research, 2018 Type 2 diabetes (T2D) accounts for about 90% of all diabetes patients and incurs a heavy global public health burden. Up to 50% of T2D patients will eventually develop neuropathy as T2D progresses.
Hong Shen +3 more
doaj +1 more source
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022 Background Diabetes mellitus is commonly complicated by diabetic peripheral neuropathy. Poor adherence to medication is common in diabetic peripheral neuropathy mainly due to common side effects and poor tolerance to medication.
Dina Elsayed Gaber, Hany M. El Deeb
doaj +1 more source
Diabetic Peripheral Neuropathy: Diagnosis and Treatment.
Current Drug Safety, 2020 BACKGROUND Diabetic peripheral neuropathy (DPN) is traditionally divided into large- and small fibre neuropathy (SFN). Damage to the large fibres can be detected using nerve conduction studies (NCS) and often results in a significant reduction in ...
J. Røikjer, C. Mørch, N. Ejskjaer
semanticscholar +1 more source
Spotlight on nerves: Portable multispectral optoacoustic imaging of peripheral nerve vascularization and morphology [PDF]
arXiv, 2022 Various morphological and functional parameters of peripheral nerves and their vascular supply are indicative of pathological changes due to injury or disease. Based on recent improvements in optoacoustic image quality, we explore the ability of multispectral optoacoustic tomography, in tandem with ultrasound imaging (OPUS), to investigate the vascular
arxiv
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
Frontiers in EndocrinologyDiabetic peripheral neuropathy (DPN) refers to the development of peripheral nerve dysfunction in patients with diabetes when other causes are excluded. Diabetic distal symmetric polyneuropathy (DSPN) is the most representative form of DPN. As one of the
Jinxi Zhu +8 more
semanticscholar +1 more source